Study | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Roche’s Arthritis Drug Decreases Deaths in Hospitalized Covid-19 Patients

Rebecca Urena02/11/2021

2282

Roche (OTCMKTS: RHHBY), a Swiss multinational healthcare company’s arthritis drug, tocilizumab, was found to reduce death in hospitalized patients with severe Covid-19. According to researchers at the University of...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz

AstraZeneca Vaccine Suspended in South Africa

Rebecca Urena02/08/202102/08/2021

3437

AstraZeneca (OTCMKTS: AZNCF), Swedish drugmaker’s, Covid-19 vaccine proved to be as little as 10% effective against South Africa’s new coronavirus variant, according to a study. The country has now...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Bionano Genomics (NASDAQ: BNGO) Skyrockets Following its Study on Autism Risk Genes

financial buzz01/04/2021

2262

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Bionano Genomics Skyrockets Following its Study on Autism Risk Genes” Bionano Genomics (NASDAQ: BNGO) surged over 69% in...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Moderna Reports First Adolescent Partakers in Study of COVID-19 Vaccine Candidate

David Kim12/11/2020

3441

Moderna Inc. (NASDAQ: MRNA) has reported its first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the company’s vaccine candidate to treat coronavirus in adolescents...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical The Market Buzz

Oxford-AstraZeneca Vaccine Receives Green Light from Researchers

Rebecca Urena12/08/202012/08/2020

2703

AstraZeneca (OTCMKTS: AZNCF), a British-Swedish multinational pharmaceutical, along with Oxford University created a coronavirus vaccine which is the first to have its late-stage trial results independently reviewed and published...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

“The Buzz” Show: Vertex (NASDAQ: VRTX) Down 20% After Discontinuing VX-814 Study

financial buzz10/15/202010/15/2020

7873

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Vertex Down 20% After Discontinuing VX-814 Study” Vertex Pharmaceuticals (NASDAQ: VRTX) is down more than 20% from previous...

Tag: Study